Vertex's drug for almost all cystic fibrosis patients approved five months early By: Boston Business Journal via Business Journals October 21, 2019 at 15:16 PM EDT The FDA approved a combination of three drugs Monday called Trikafta, which targets a mutation in the F508del gene. Read More >>
